Drug Profile
Research programme: pneumococcal conjugate vaccines - Chengdu Institute of Biological Products
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Chengdu Institute of Biological Products
- Class Bacterial vaccines; Conjugate vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pneumococcal infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Pneumococcal-infections in China
- 20 Aug 2012 Early research in Pneumococcal infections in China (unspecified route)